Physician profile
Theresa Mottes
NPI 1255841748
$24,829.63
in general payments reported to CMS, 2019-2025
6 companies · $8,459 in 2025
The $8,459 reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,380 · 2023: $2,178 · 2024: $7,813 · 2025: $8,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,200 · Education: $4,410 · Travel and Lodging: $4,355 · Food and Beverage: $2,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,200.00 |
| Education | $4,410.00 |
| Travel and Lodging | $4,355.02 |
| Food and Beverage | $2,484.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $9,604.46 | 2023-2024 | Renal - Acute |
| Vantive US Healthcare LLC | $8,459.07 | 2025 | Renal - Acute |
| Medtronic, INC. | $6,380.00 | 2021 | |
| Vifor Pharma, INC. | $203.64 | 2024 | Veltassa |
| Mozarc Medical US LLC | $120.76 | 2023-2024 | Carpediem |
| Nuwellis, INC. | $61.70 | 2023-2024 | Aquadex Smartflow Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theresa Mottes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.